Comparing the carbon footprint of endoscopic ultrasound versus MRCP for suspected common bile duct stones

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure and compare greenhouse gas emissions (CO2e) associated with diagnostic MRCP and EUS performed for adults with intermediate likelihood of CBD stones at a single tertiary center. Participants are adults referred for either MRCP or EUS per standard clinical care, and the trial will capture energy use, equipment and facility contributions, and downstream procedure needs such as same-session ERCP. The design builds on prior randomized data showing similar diagnostic performance between the two tests and prior work suggesting lower emissions from EUS. Results will be reported as per-procedure carbon footprints to inform more sustainable diagnostic choices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Intermediate likelihood of CBD stone (per ESGE)
* Undergoing either MRCP or EUS for evaluation

Exclusion Criteria:

* High or low likelihood category (per ESGE)
* Undergoing both MRCP and EUS simultaneously
* Contraindications to either modality

Where it's running

• AIG Hospitals
  Hyderabad, Telangana, India Recruiting

Study contacts

• Study coordinator: Dr.Hardik Rughwani
• Email: dr.hardikr@aighospitals.com
• Phone: 9426928600

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis

  This study tests whether giving hyoscine butylbromide during laparoscopic transcystic papillary balloon dilation helps patients with common bile duct stones by making the procedure faster or easier.

  Recruiting Riga East Clinical University Hospital · Riga · NCT07814976

• Holmium laser versus electrohydraulic lithotripsy for difficult bile duct and pancreatic duct stones

  This will test whether a low-power holmium laser works and is as safe as electrohydraulic lithotripsy for adults with large or hard-to-remove bile duct or pancreatic duct stones.

  Recruiting Phase 4 Rush University Medical Center · Chicago, Illinois · NCT07418112

• Intraductal antibiotic given during ERCP for acute cholangitis

  This trial tests whether putting an antibiotic directly into the bile ducts during ERCP, together with standard IV antibiotics, helps adults with mild-to-moderate acute cholangitis recover faster and avoid worsening infection compared with IV antibiotics alone.

  Recruiting Phase 2 National University of Malaysia · Cheras, Kuala Lumpur · NCT07407491

• Early versus late laparoscopic gallbladder removal after clearing common bile duct stones with ERCP

  This trial will test whether having your gallbladder removed soon after ERCP or waiting longer gives better outcomes for people who had stones cleared from their common bile duct.

  Recruiting Khyber Teaching Hospital · Peshawar, Khyberpukhtunkhwa · NCT07130864

• One-stage laparoendoscopic approach for gallbladder and common bile duct stones

  This trial tests whether a single-operation laparoendoscopic 'rendezvous' approach—combining laparoscopic gallbladder removal with endoscopic bile duct clearance—works safely and effectively for patients with both gallbladder and common bile duct stones.

  Recruiting Minia University · Minya · NCT07008170

• Gallbladder removal versus watchful waiting after bile duct stone removal in older adults

  This trial tests whether immediate laparoscopic gallbladder removal or a wait-and-see approach is better for older patients after their common bile duct stones have been removed by ERCP.

  Recruiting at 2 sites Helsinki University Central Hospital · Espoo and 11 other locations · NCT07001423

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.